Consolidated balance sheet
Assets | |||||
in CHF 1,000 | Note | 30.06.2021 | 31.12.2020 | Variance | Variance |
|---|---|---|---|---|---|
|
|
|
| absolute | in % |
Cash and cash equivalents |
| 2,408,082 | 2,592,706 | –184,624 | –7.1 |
Receivables arising from money-market papers |
| 106,676 | 116,166 | –9,490 | –8.2 |
Due from banks |
| 1,598,192 | 1,784,320 | –186,128 | –10.4 |
Due from customers |
| 6,522,462 | 6,281,529 | 240,933 | 3.8 |
Trading portfolios |
| 3,010 | 290 | 2,720 | n.a. |
Derivative financial instruments |
| 95,318 | 79,491 | 15,827 | 19.9 |
Financial instruments at fair value | 195,270 | 182,936 | 12,334 | 6.7 | |
Financial instruments measured at amortised cost | 2,333,991 | 2,201,303 | 132,688 | 6.0 | |
Joint venture companies |
| 24 | 25 | –1 | –4.0 |
Property and equipment | 101,845 | 108,156 | –6,311 | –5.8 | |
Goodwill and other intangible assets |
| 75,854 | 66,679 | 9,175 | 13.8 |
Tax receivables |
| 208 | 159 | 49 | 30.8 |
Deferred tax assets |
| 9,179 | 10,173 | –994 | –9.8 |
Accrued receivables and prepaid expenses |
| 36,274 | 32,429 | 3,845 | 11.9 |
Other assets |
| 12,712 | 66,989 | –54,277 | –81.0 |
Total assets |
| 13,499,097 | 13,523,351 | –24,254 | –0.2 |
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and shareholders’ equity |
|
|
|
|
|
in CHF 1,000 | Note | 30.06.2021 | 31.12.2020 | Variance | Variance |
|
|
|
| absolute | in % |
Due to banks |
| 184,006 | 250,426 | –66,420 | –26.5 |
Due to customers – savings and deposits |
| 593,136 | 589,784 | 3,352 | 0.6 |
Due to customers – other liabilities |
| 11,125,527 | 10,921,871 | 203,656 | 1.9 |
Derivative financial instruments |
| 61,712 | 104,371 | –42,659 | –40.9 |
Medium-term notes |
| 54,357 | 76,148 | –21,791 | –28.6 |
Debentures issued | 255,160 | 355,205 | –100,045 | –28.2 | |
Tax liabilities |
| 12,782 | 12,208 | 574 | 4.7 |
Deferred tax liabilities |
| 956 | 141 | 815 | n.a. |
Accrued liabilities and deferred items |
| 32,867 | 36,085 | –3,218 | –8.9 |
Other liabilities | 127,252 | 151,243 | –23,991 | –15.9 | |
Provisions |
| 705 | 812 | –107 | –13.2 |
Total liabilities |
| 12,448,460 | 12,498,294 | –49,834 | –0.4 |
Share capital | 66,154 | 66,154 | 0 | 0.0 | |
Less: treasury shares | –57,154 | –61,071 | 3,917 | 6.4 | |
Capital reserves |
| 22,462 | 23,377 | –915 | –3.9 |
Income reserves |
| 1,113,347 | 1,107,739 | 5,608 | 0.5 |
Actuarial gains/losses from defined-benefit |
| –49,322 | –57,859 | 8,537 | 14.8 |
Unrealised gains/losses on FVTOCI financial instruments |
| –17,688 | –23,332 | 5,644 | 24.2 |
Foreign-currency translation differences |
| –27,162 | –29,951 | 2,789 | 9.3 |
Total shareholders’ equity |
| 1,050,637 | 1,025,057 | 25,580 | 2.5 |
Total liabilities and shareholders’ equity |
| 13,499,097 | 13,523,351 | –24,254 | –0.2 |